In this study, Roy et al. [190] found that ALDH1A1-positive tumours were three times more likely than ALDH1A1-negative tumours to show platinum refractoriness (17% vs. 6; p = 0.04). This evidence concerns the gene ALDH1A1 and neoplasm.